NCT04853797View on ClinicalTrials.gov

Effect of Ivabradine on Levcromakalim-Induced Symptoms in Individuals With Migraine Without Aura (ILIM)

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 16, 2021

Primary Completion Date

January 1, 2025

Study Completion Date

January 1, 2025

Conditions
HeadacheMigraine Without Aura
Interventions
DRUG

Levcromakalim

20 min infusion of 1 mg Levcromakalim followed by either oral Ivabradine or Placebo.

DRUG

Ivabradine

15 mg oral Ivabradine.

DRUG

Placebo

Oral placebo (calcium supplements).

Trial Locations (2)

2600

RECRUITING

Danish Headache Centre, Rigshospitalet-Glostrup, Glostrup

RECRUITING

Danish Headache Center, Glostrup Municipality

All Listed Sponsors
lead

Danish Headache Center

OTHER